Latest stories on KLRA
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Yahoo Finance73 · bullishproduct/pr
Kailera Therapeutics: A Second-Wave Obesity Platform With More Than One Way To Win
Seeking Alpha67 · bullishproduct/pr
Kailera's oral weight loss pill met its trial goal, but nausea hit 70% of patients
Quartz38 · neutralproduct/pr
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
Investors.com67 · bullishgeneral
Kailera falls after late-stage trial data for oral GLP-1 candidate
Seeking Alpha34 · bearishproduct/pr
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer | KLRA Stock News
StockTitan56 · neutralproduct/pr
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026 | KLRA Stock News
StockTitan73 · bullishproduct/pr
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference | KLRA Stock News
StockTitan56 · neutralgeneral
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates | KLRA Stock News
StockTitan50 · neutralgeneral
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Yahoo Finance57 · neutralanalyst
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
Yahoo Top56 · neutralanalyst
Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity
Investors.com58 · neutralgeneral